Welcome to our dedicated page for Waystar Holding SEC filings (Ticker: WAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Waystar Holding Corp. (Nasdaq: WAY) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Waystar operates as a healthcare payment software and health information services company, and its filings offer detailed insight into its financial condition, capital structure, and significant corporate events.
Investors can review Form 8-K current reports in which Waystar discloses material events such as quarterly earnings announcements, amendments to its credit agreements, and the completion of acquisitions. For example, the company has filed 8-Ks describing results for specific fiscal quarters, the execution of amendments to its First Lien Credit Agreement, and the closing of the acquisition of Iodine Software, including information about consideration paid and related financing arrangements.
Waystar’s filings also address topics such as its status as an emerging growth company, underwritten secondary offerings by selling stockholders, and stockholder and lockup agreements associated with strategic transactions. These documents provide context on ownership dynamics, board composition changes, and registration rights for significant investors.
On this page, Stock Titan surfaces real-time updates from the SEC’s EDGAR system so that new Waystar filings appear promptly. AI-powered summaries help explain the key points of lengthy documents, highlighting items like revenue and earnings disclosures in earnings-related 8-Ks, terms of material definitive agreements, and details of merger and acquisition transactions. Users can quickly understand what each filing covers without reading every page.
In addition to 8-Ks, investors can use this page to locate Waystar’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, as well as any proxy statements or registration statements referenced in the company’s disclosures. For those tracking governance and ownership, insider transaction reports on Form 4 can also be accessed to monitor equity activity by directors and officers.
By combining structured access to Waystar’s SEC filings with AI-generated explanations, this page is intended to make it easier to analyze complex regulatory documents, follow the company’s financing and M&A activity, and understand the legal and financial context behind its healthcare payment software business.
Waystar Holding (WAY) filed a routine Form 4 for Chief Business Officer Eric L. Sinclair III. On 06/25/2025 he exercised 9,702 options at $4.14 (Code M) and immediately sold 9,702 shares at a weighted-average $40.2243 under a 10b5-1 plan adopted 02/19/2025.
The sale is valued at roughly $391 k, represents ~2 % of his 500,572-share position, and leaves him with 490,870 shares (including unvested RSUs). No other material changes were disclosed.
Eric L. Sinclair III (Ric), Chief Business Officer of Waystar Holding Corp (WAY), executed planned transactions under Rule 10b5-1(c) on June 20, 2025:
- Exercised 9,702 stock options at $4.14 per share
- Immediately sold 9,702 shares at weighted average price of $37.7877 (range: $37.65-$38.09)
- Post-transaction holdings: 490,870 shares (direct ownership, including unvested RSUs) and 126,118 stock options
These transactions were executed automatically according to a trading plan established on February 19, 2025. The significant spread between exercise price ($4.14) and sale price ($37.7877) resulted in substantial gains. The executive maintains a considerable equity position in the company following the transaction.